Literature DB >> 7586324

Clinical misconceptions dispelled by epidemiological research.

W B Kannel1.   

Abstract

The epidemiological approach to investigation of cardiovascular disease was innovated in 1948 by Ancel Keys' Seven Countries Study and T.R. Dawber's Framingham Heart Study. Conducted in representative samples of the general population, these investigations provided an undistorted perception of the clinical spectrum of cardiovascular disease, its incidence and prognosis, the lifestyles and personal attributes that predispose to cardiovascular disease, and clues to pathogenesis. The many insights gained corrected numerous widely held misconceptions derived from clinical studies. It was learned, for example, that the adverse consequences of hypertension do not derive chiefly from the diastolic pressure, left ventricular hypertrophy was not an incidental compensatory phenomenon, and small amounts of proteinuria were more than orthostatic trivia. Exercise was considered dangerous for cardiovascular disease candidates; smoking, cholesterol, and a fatty diet were regarded as questionable promoters of atherosclerosis. The entities of sudden death and unrecognized myocardial infarction were not widely appreciated as prominent features of coronary disease, and the disabling and lethal nature of cardiac failure and atrial fibrillation was underestimated. It took epidemiological research to coin the term "risk factor" and dispel the notion that cardiovascular disease must have a single origin. Epidemiological investigation provided health professionals with multifactorial risk profiles to more efficiently target candidates for cardiovascular disease for preventive measures. Clinicians now look to epidemiological research to provide definitive information about possible predisposing factors for cardiovascular disease and preventive measures that are justified. As a result, clinicians are less inclined to regard usual or average values as acceptable and are more inclined to regard optimal values as "normal." Cardiovascular events are coming to be regarded as a medical failure rather than the first indication of treatment.

Entities:  

Mesh:

Year:  1995        PMID: 7586324     DOI: 10.1161/01.cir.92.11.3350

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Poor compliance: the hidden risk factor.

Authors:  J C LaRosa
Journal:  Curr Atheroscler Rep       Date:  2000-01       Impact factor: 5.113

2.  Cardiology's 10 greatest discoveries of the 20th century.

Authors:  Nirav J Mehta; Ijaz A Khan
Journal:  Tex Heart Inst J       Date:  2002

Review 3.  Swimming exercise: impact of aquatic exercise on cardiovascular health.

Authors:  Hirofumi Tanaka
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

4.  Invited Commentary: The Framingham Offspring Study-A Pioneering Investigation Into Familial Aggregation of Cardiovascular Risk.

Authors:  JoAnn E Manson; Shari S Bassuk
Journal:  Am J Epidemiol       Date:  2017-06-01       Impact factor: 4.897

5.  Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.

Authors:  J W Knowles; G Esposito; L Mao; J R Hagaman; J E Fox; O Smithies; H A Rockman; N Maeda
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

6.  A literature review of the cardiovascular risk-assessment tools: applicability among Asian population.

Authors:  Siow Yen Liau; M I Mohamed Izham; M A Hassali; A A Shafie
Journal:  Heart Asia       Date:  2010-07-06

Review 7.  Sudden cardiac death: epidemiology and risk factors.

Authors:  A Selcuk Adabag; Russell V Luepker; Véronique L Roger; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2010-02-09       Impact factor: 32.419

Review 8.  Cost effectiveness of coronary heart disease prevention strategies in adults.

Authors:  A D Brown; A M Garber
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

9.  Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298-->Asp polymorphism) to the presence, extent, and severity of coronary artery disease.

Authors:  M G Colombo; M G Andreassi; U Paradossi; N Botto; S Manfredi; S Masetti; G Rossi; A Clerico; A Biagini
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

10.  Statins: past and present.

Authors:  Rachel Hajar
Journal:  Heart Views       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.